Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Balaji Amines Ltd Performance

Today's Low
2,215.00
arrowIcon
Today's High
2,259.95
52 Wk Low
1,880.00
arrowIcon
52 Wk High
2,735.00


Open

2248.05

Traded Value (Cr)

1.38 Cr

Prev. Close

2228.5

VWAP

2216.75

Volume

46,741

Face Value

2

Balaji Amines Ltd Fundamentals

Market Cap
₹ 7,434 Cr
P/E Ratio (TTM)
40.36
P/B Ratio
4.62
Debt to Equity
0.03
ROE
12.27 %
EPS (TTM)
56.86
Dividend Yield
0.44%
Book Value
496.43

Click here to know more about Fundamentals

Balaji Amines Ltd Financials

Balaji Amines Ltd Financials

Balaji Amines Ltd Shareholding Pattern

Held By Dec 2023 Sep 2023 Jun 2023 Mar 2023
Promoters 53.70 % 53.70 % 53.70 % 53.70 %
Retail 35.17 % 35.62 % 36.28 % 36.10 %
Others 6.49 % 6.09 % 5.39 % 5.66 %
FII 4.57 % 4.52 % 4.55 % 4.46 %
Mutual Funds 0.07 % 0.07 % 0.09 % 0.09 %

Promoters

53.70%

Retail

35.17%

Others

6.49%

FII

4.57%

Mutual Funds

0.07%

Promoters

53.70%

Retail

35.62%

Others

6.09%

FII

4.52%

Mutual Funds

0.07%

Promoters

53.70%

Retail

36.28%

Others

5.39%

FII

4.55%

Mutual Funds

0.09%

Promoters

53.70%

Retail

36.10%

Others

5.66%

FII

4.46%

Mutual Funds

0.09%

Resistance and Support

₹2,201.85

PIVOT

resistance-arrow
Resistance
First Resistance₹2,246.400
Second Resistance₹2,298.050
Third Resistance₹2,342.600
support-arrow
Support
First Resistance₹2,150.200
Second Resistance₹2,105.650
Third Resistance₹2,054.000
RSI59.176
MACD89.745
ADX14.252
CCI60.923

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day46,74114,86231.80
Week112,77838,79257.14
1 Month117,67036,34341.69
6 Months69,89569,895100.00

About Balaji Amines Ltd

Promoted by the KPR Group of Industries, Balaji Amines Ltd. (BAL) was incorporated on 27th October, 1988. The Company is a leading manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals, Aliphatic Amines and Derivatives. Apart from this, it has now diversified into producing derivatives of methyl and ethyl amines, namely, Di-Methyl Amine Hydrochloride (DMA-HCl), Choline Chloride, Di Methyl Acetamide, etc. At present, the Company supply to various Blue Chip Companies like IDI, Hoechst, Rallis, Ion Exchange, Cheminor Drugs, TTK Pharma, etc. It has four manufacturing facilities, three plants at Tuljapur and Chincholi in Maharashtra and one at Medak, Telangana. It owns a Five Star Hotel in Solapur, Maharashtra and has CFL lamps facility at Medak, Telangana. The Company presently operates in three segments i.e., Specialty Chemicals and Amines, Hotel and CFL Lamps. A new facility for manufacture of Speciality Chemicals is under construction at Chicholi, Maharashtra. On May '95, it came out with a public issue of 9.63 lac equity shares (premium : Rs 30), aggregating Rs 3.85 cr to part-finance expansion plans for ethylamines and forward integration for the manufacture of derivatives of methyl and ethyl amines, totaling to Rs 10 cr. In 1988, the Company started business operations. In 1989, it started to produce Methyl Amines and Ethyl Amines. In 1992, the Company established R&D Centre at Hyderabad. In 1995, it started manufacturing drug intermediate -Dimethyl Amine Hydrochloride. In 1997-98, the company has successfully commenced the commercial operation of its main plant (Ethyl Amines) from June, 1997. In 2000, it added derivatives of Methyl and Ethyle Amines to the product portfolio. In 2001, the Company was certified with ISO:9001. Expansion programme has been taken up for value-added products like Choline Chloride, DMAE-HCI and other intermediates at a cost of Rs.500 lacs. The project has been appraised by State Bank of Hyderabad and Bank of India for a term loan of Rs.290 lacs and Rs.100 lacs respectively.The balance would be met out by the internal accruals of the company.The project would be implemented on phases and the first phase is likely to be commissioned during the current year 2001-2002. During the year 2003, Company was awarded 'Recognized Export House' status from Government of India, Ministry of Commerce, New Delhi. It increased the capacity of Methyl Amines. In 2005, the Company developed more specialty chemicals. In 2006, it founded Balaji Foundation and Research Centre for the rural population as a part of CSR activity. It became the sole manufacturer of GBI, NMP, and Morpholine. During the year 2009, the Company started power generation through windmill by establishing 1.5 MW windmill unit at Satara, Maharashtra. It established an R & D GBL Plant at Tamalwadi, Solapur. It commenced setting up 2.5 MW Co-Generation Power Plant Unit at Tamalwadi and PVP Plant at Chincholi, in Solapur respectively. Apart from this, it secured the Certificate of Merit' for Outstanding Export by Chemexcil. During the year 2010, 2.5 Mw Co- Generation Power Plant at Tamalwadi, Solapur has been commissioned in July, 2009. Besides this, the PVP Plant at Chincholi, Solapur has started producing various grades and the mandatory approvals are in final stages. In 2010, the Company installed wind turbine for generating in-house electricity to start focusing on renewable energy. In 2012, the Company received 'Certificate of Suitability' certification from European Directorate for the Quality Medicines & Health Care (EDQM), Europe for its product PVPK-30. It also received WHOGMP certification and REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) for four products namely, Triethylamine, Gammabutyrolactone, N-Ethylamine-2-Pyrrolidone along with the already registered N-methyl 2 Pyrrolidone (NMP). It has been awarded for the category of 'Best Manufacturer - Exporter (Medium)' at the Indian Exporter Excellence Awards 2012 instituted by the Export Credit Guarantee Corporation of India Limited (ECGC)[An Indian Govt. Undertaking], in association with Dun and Bradstreet (D&B), which seeks to recognize leading exporters for their excellence in their respective fields. In October 2013, the Company inaugurated its 129 Room Five-Star Hotel Property Balaji Sarovar Premiere' with an investment of Rs. 110 crore. It executed the commissioning of DMF manufacturing Plant. Further, two new plants, one for the first phase of Di-Methyl Amine Hydrochloride (DMA-HCL) with an installed capacity of 7500 MT per annum commissioned in the month of February, 2013 and second plant for manufacture of Di Methyl Formamide (DMF) with an installed capacity of 30000 MT / P. A at MIDC Chincholi, Solapur has been commissioned in the month of March, 2013. During the year 2013, Company's 5 star Hotel Property started commercially from 1st November 2013 which is being managed by Sarovar Group of Hotels. In 2014, the Company was awarded for Balaji Sarovar Premium's eco-friendly Green technology'. During the year 2015, Company successfully re-commissioned its DMF plant by strengthening the Carbon Monoxide plan. In 2015, it was awarded another Certificate of Excellence' for Balaji Sarovar Premiere from the Trip Advisor on the basis of customer reviews for excellent food, service and hospitality. In 2016, it set up a plant to manufacture Acetonitrile. During the year 2017-18, the subsidiaries of the Company viz. Bhagyanagar Chemicals Limited (company's holding 100%) and Balaji Greentech Products Limited (company's holding 66%) were amalgamated with BAL (the Company) as per the scheme of amalgamation sanctioned by the Hon'ble NCLT, Mumbai. In 2018, the Company was 90 acres of land at MIDC, Chincholi with Mega Project Status for this new project by Maharashtra State Government. It commissioned a new plant for manufacture of Morpholine and Acetonitrile after successful trial runs. In 2019, the Company set up a new plant project under its subsidiary, Balaji Specialty Chemicals Private Limited, which got completed in a record 12 months. In 2021, Company commenced operation in Greenfield Project at Unit-IV. The Boiler of 50 TPH capacity was commissioned during FY 2021-22, with a capex of Rs 19.76 Crores. The Company commissioned a New Ethylamines Plant Phase I of its Greenfield Project. During FY 23, the Company commissioned Phase I (Unit IV) DMC, PG and PC plants, comprising the production capacity of 15,000 tons of Di-methyl Carbonate (DMC)/ Propylene Carbonate (PC) and 15,000 tons of Propylene Glycol (PG).

Managing Director

D Ram Reddy

Founded

1988

NSE Symbol

BALAMINES

Balaji Amines Ltd Management

NameDesignation
A Prathap ReddyExecutive Chairman
N Rajeshwar ReddyJoint Managing Director
D Ram ReddyManaging Director
A Srinivas ReddyWhole Time Director & CFO
Lakhan Suganchand DargadCompany Sec. & Compli. Officer
Suhasini Y ShahIndependent Director
Adabala Seshagiri RaoIndependent Director
Uma Rajiv PradhanIndependent Director
R. Mohan KumarIndependent Director

Balaji Amines Ltd News

Balaji Amines receives affirmation in credit ratings
Balaji Amines consolidated net profit declines 21.10% in the December 2023 quarter
Sales decline 34.57% to Rs 383.36 crore
Balaji Amines to announce Quarterly Result
On 31 January 2024
Balaji Amines gets BIS certification for ‘Morpholine’
Balaji Amines announced that the specialty chemical maker has received BIS Certification for the product ‘Morpholine’ from the Bureau of Indian Standards (BIS), Ministry of Consumer Affairs.
Balaji Amines rises as project gets 'mega project' status by Maharashtra Govt
Balaji Amines added 3.02% to Rs 2675 after the Industries, Energy and Labour Department, Government of Maharashtra has approved conferring 'mega project' status to the company’s Solapur expansion project.
Volumes soar at Balaji Amines Ltd counter
Balaji Amines Ltd clocked volume of 11.93 lakh shares by 14:14 IST on NSE, a 33.87 times surge over two-week average daily volume of 35219 shares
Balaji Amines consolidated net profit declines 62.50% in the September 2023 quarter
Sales decline 39.39% to Rs 380.54 crore
Balaji Amines to conduct board meeting
On 8 November 2023
Balaji Amines subsidiary Balaji Speciality Chemicals withdraws DRHP
Balaji Amines said that its material subsidiary, Balaji Speciality Chemicals (BSCL) has withdrawn the DRHP filed with SEBI on 8 September 2023.
Balaji Amines Q1 PAT slides 57% YoY to Rs 53 cr
Balaji Amines announced that its consolidated net profit declined 57.1% to Rs 52.73 crore in Q1 FY24 from Rs 122 crore posted in Q1 FY23.

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
PIDILITIND₹ 1,46,433 Cr
₹ 2,879.10
(-0.15 %)
84.42
SRF₹ 74,647 Cr
₹ 2,518.25
(-1.53 %)
49.17
LINDEINDIA₹ 58,986 Cr
₹ 6,916.85
(1.71 %)
140.03
FLUOROCHEM₹ 38,717 Cr
₹ 3,524.55
(-1.54 %)
56.36
DEEPAKNTR₹ 31,669 Cr
₹ 2,321.90
(1.00 %)
75.69

Balaji Amines Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Balaji Amines Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Balaji Amines Ltd's share price is ₹2,215.00 as of April 18, 2024

Balaji Amines Ltd's P/E ratio is 40.36 times as of April 18, 2024.

Balaji Amines Ltd's most recent financial reports indicate a price-to-book ratio of 4.62, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Balaji Amines Ltd's market is 7,435 Cr as on April 18, 2024.

The current financial records of Balaji Amines Ltd show a 12.27% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Balaji Amines Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Balaji Amines Ltd's 52-week high and low as of April 18, 2024 are ₹2259.95 and ₹2215 respectively.

As of the Dec 2023 quarter, the promoter shareholding in Balaji Amines Ltd stands at 53.70%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 4.52% to 4.57%.